NCT06019533View on ClinicalTrials.gov

A Trial on Contraceptive Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Contraception
Interventions
COMBINATION_PRODUCT

LVDS

Levonorgestrel Vaginal Delivery System

Trial Locations (1)

28938

LR-301/, Móstoles

Sponsors

Lead Sponsor

Chemo Research
All Listed Sponsors
lead

Chemo Research

INDUSTRY